Meningococcemia in vaccinated patient under treatment with eculizumab;Infección meningocócica en paciente vacunado y en tratamiento con eculizumab

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 35, Issue 3, 2017, Pages 200-201

  Hernando Real, Susana ^a   Vega Castaño, Silvia ^a   Pajares García, Rafael ^a  

^a HOSPITAL GENERAL DE SEGOVIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ECULIZUMAB; MENINGOCOCCUS VACCINE; 4CMENB VACCINE; ANTIINFECTIVE AGENT; BACTERIAL ANTIGEN; CEFOTAXIME; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY;

ARTICLE; HUMAN; MENINGOCOCCEMIA; PATIENT; VACCINATION; ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; BACTERIUM IDENTIFICATION; CASE REPORT; CLASSIFICATION; COMPLICATION; EMERGENCY; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; MENINGOCOCCOSIS; MICROBIOLOGY; NEISSERIA MENINGITIDIS; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; VACCINE IMMUNOGENICITY; YOUNG ADULT;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIGENS, BACTERIAL; BACTEREMIA; BACTERIAL TYPING TECHNIQUES; CEFOTAXIME; EMERGENCIES; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGENICITY, VACCINE; IMMUNOSUPPRESSIVE AGENTS; MALE; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS; VACCINATION; YOUNG ADULT;

EID: 84961119870     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2016.02.015     Document Type: Article

References (6)

1. 1 Urbano-Ispizua, A., Gaya, A., Colado, E., López, M., Arrizabalaga, B., Vicente, V., et al. Diagnosis and treatment of nocturnal paroxismal hemoglobinutia. Med Clin (Barc) 136 (2011), 121–127.
2. 2 Eculizumab. [consultado 30 Sep 2015]. Disponible en: http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-_Product_Information/human/000791/WC500054208.pdf.
3. 3 Cruz, S.C., Souza, S.L., Cruz, A.C., Silva, G.P., Milagres, L.G., Humane antibody and memory B and T-cell responses after primary and booster inmunisation against Neisseria meningitidis B. Vaccine 29 (2011), 7387–7394.
4. 4 Gil, A., Barranco, D., Batalla, J., Bayas, J.M., Camping, M., Gorrotxategi Gorrotxategi, P., et al. Prevención de la enfermedad meningocócica por el serogrupo B mediante una vacuna de cuatro componentes. Rev Pediatr Aten Primaria 16 (2014), 108.e55–108.e74.
5. 5 Bai, X., Findlow, J., Borrow, R., Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles. Expert O Biol Ther 11 (2011), 969–985.
6. 6 Vogel, U., Taha, M.K., Vazquez, J.A., Findlow, J., Claus, H., Vogel, U., et al. Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: A qualitative and quantitative assessment. Lancet Infect Dis 13 (2013), 416–425.